Skip to content
Use case · Metabolic
UUse case · Metabolic

Peptides in metabolic research

Metabolic peptides carry the strongest human evidence on the site. They also make the clearest case for the clinical channel over the research channel.

GLP-1 science anchors this category. Semaglutide has extensive randomized human trial data and an FDA approval.

That evidence comes from the clinical channel, not the research-chemical channel. The same sequence sold as a research chemical carries none of the oversight.

Read the regulatory status on each profile. For approved compounds, a licensed prescriber is the only route with real safety oversight.

Amber liquid dropped from a pipette into a glass beaker
metabolic

Evidence and status, side by side

CompoundEvidence gradeRegulatory statusProfile
SemaglutideEstablishedFDA-approved as a prescription drug. Obtain only through licensed clinical channels.Open →
TesamorelinEstablishedFDA-approved for a specific clinical indication. Prescription-only.Open →
MetabolicEstablished

Semaglutide

A GLP-1 receptor agonist with extensive human clinical trial data for metabolic endpoints.

Growth HormoneEstablished

Tesamorelin

A GHRH analog with FDA-approved clinical indications and strong human data.

Open the full Evidence Library